Patient care navigation and health copilot AI
Carey
Carey describes user-requested calls, scheduling, refill coordination, and human assistance. Delegated help can support a patient’s chosen task. Task approval, mid-task revocation, caregiver authority, and current legal terms remain incompletely verified.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 76 out of 100 toward patient-directed
Family-facing administrative concierge with AI and human assistance. Patient authority must be distinguished from a caregiver's authority to act.
Potentially agency-expanding
Carey describes user-requested calls, scheduling, refill coordination, and human assistance. Delegated help can support a patient’s chosen task. Task approval, mid-task revocation, caregiver authority, and current legal terms remain incompletely verified.
Patient agency
How this tool changes agency
Status visibility supports coordination. It does not by itself establish an inspectable call record or a way to challenge an incorrect action.
Task-level authorization, human access, revocation and current legal terms remain unresolved
Patient agency assessment
Who sets and changes the goal?
The described workflow begins with the user's task. Completion of calls can expand practical authority, but the pages do not establish approval boundaries, revocation mid-task or safeguards when family and patient wishes differ.
What can the patient understand, question, or do?
Status visibility supports coordination. It does not by itself establish an inspectable call record or a way to challenge an incorrect action.
Can the patient evaluate the conditions of use?
Current marketing confirms AI and human involvement. The historical legal-versus-marketing tension remains unresolved because current terms did not render, not because bad practice was demonstrated.
Text findings
Conditions of use
Published controls and their limits
Current marketing confirms AI and human involvement. The historical legal-versus-marketing tension remains unresolved because current terms did not render, not because bad practice was demonstrated.
What remains unknown?
Not tested or not established
Task-level authorization, human access, revocation and current legal terms remain unresolved
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Task-level authorization, human access, revocation and current legal terms remain unresolved No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Low to moderate (AI-assisted draft)